back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-04-01 16:02 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: Samantha Nutt (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+16,666 vol |
16,666 | |
| Filed 2026-04-01 16:01 Tx date 2023-06-29 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: Samantha Nutt (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-04-01 16:00 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: Samantha Nutt (Indirect Ownership)
|
Convertible Debentures 1.25%/Month, Maturing March 20, 2028
11 - Acquisition or disposition carried out privately
|
+$50,000 vol |
$50,000 | |
| Filed 2026-04-01 16:00 Tx date 2023-06-29 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: Samantha Nutt (Indirect Ownership)
|
Convertible Debentures 1.25%/Month, Maturing March 20, 2028
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-04-01 15:58 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$16,667,000
+16,667 vol $1,000 each |
516,667 | |
| Filed 2026-04-01 15:57 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 1.25%/Month, Maturing March 20, 2028
16 - Acquisition or disposition under a prospectus exemption
|
$
+$50,000 vol $1,000 each |
$50,000 | |
| Older filings | ||||||
| Filed 2026-03-23 16:09 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$33,333,000
+33,333 vol $1,000 each |
||
| Filed 2026-03-23 16:03 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 1.25%/Month, Maturing March 20, 2028
16 - Acquisition or disposition under a prospectus exemption
|
$
+$100,000 vol $1,000 each |
||
| Filed 2026-03-23 16:10 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$66,666,000
+66,666 vol $1,000 each |
66,666 | |
| Filed 2026-03-23 16:09 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$33,333,000
+33,333 vol $1,000 each |
533,333 | |
| Filed 2026-03-23 16:07 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$66,666,000
+66,666 vol $1,000 each |
||
| Filed 2026-03-23 16:04 Tx date 2023-06-29 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-23 16:03 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 1.25%/Month, Maturing March 20, 2028
16 - Acquisition or disposition under a prospectus exemption
|
$
+$100,000 vol $1,000 each |
$100,000 | |
| Filed 2026-03-23 16:01 Tx date 2023-06-29 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 1.25%/Month, Maturing March 20, 2028
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-23 16:01 Tx date 2026-03-20 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Convertible Debentures 1.25%/Month, Maturing March 20, 2028
16 - Acquisition or disposition under a prospectus exemption
|
$
+$200,000 vol $1,000 each |
$200,000 | |
| Filed 2026-03-23 15:59 Tx date 2023-06-29 |
$QNTM
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Convertible Debentures 1.25%/Month, Maturing March 20, 2028
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-01-09 16:38 Tx date 2026-01-06 |
$HELP
Cybin Inc. |
Hoskins, Eric William
4 - Director of Issuer
Holder: Lucky Square Holdings Inc. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
+25,000 vol |
25,000 | |
| Filed 2026-01-09 16:38 Tx date 2020-11-05 |
$HELP
Cybin Inc. |
Hoskins, Eric William
4 - Director of Issuer
Holder: Lucky Square Holdings Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-01-09 16:37 Tx date 2026-01-06 |
$HELP
Cybin Inc. |
Hoskins, Eric William
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-25,000 vol |
0 | |
| Filed 2025-11-21 15:22 Tx date 2025-09-26 |
$N/A
Unbuzzd Wellness Inc. |
Hoskins, Eric William
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: The Hoskins Family Trust 2021 (Indirect Ownership)
|
Restricted Share Units
56 - Grant of rights
|
+1,000,000 vol |
1,000,000 | |